Abo Blood Groups As a New Potential Predictive Factor in Radiotherapy Hematological Changes Publisher Pubmed



Seyfizadeh N^{1, 3} ; Saboori H³ ; Borzoueisileh S^{3, 4} ; Habibi M^{3, 5} ; Elahimanesh F³
Source: Bratislava Medical Journal Published:2020

Abstract

AIM: Cancer treatments specially with new high Tec radiotherapy equipment's calling daily progression in method and predictive factors affecting treatment goals. Due to important effect of oxygen on cells radio sensitivity, tumor blood circulation and it's antigens like ABO blood groups maybe an important predictive factor for radiotherapy response and it is adverse events. The aim of this study was the assessment of the hematological manifestations of local radiotherapy and association with ABO blood groups. METHODS: In this observational study, 2 ml of peripheral blood were taken from 152 patients with routine 3D conformal radiotherapy treatment course and the blood parameters achieve and documented at four stage during treatment courses. The data were analyzed by repeated measurement andone-way ANOVA. RESULTS: Statistically significant reductions of the platelets, white blood cells (WBC), and lymphocytes counts were demonstrated. Also an increased percentage of polymorphonuclear cells during local radiotherapy exposure was found. The changes in WBC counts were observed to be in association with ABO blood groups. The other evaluated factors were not significantly associated with ABO blood groups. CONCLUSIONS: Our results showed an association between radiotherapy patients ABO blood groups and some hematological changes in their blood circulation (Fig. 7, Ref. 23). Text in PDF www.elis.sk. © 2020, Comenius University.